Green Cross Health Limited (NZE:GXH)
New Zealand · Delayed Price · Currency is NZD 1.965
-0.015 (-0.76%)
Jul 31, 2026, 4:44 PM NZST
Green Cross Health Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 20.4 | 15.98 | 11.76 | 45.23 | 23.9 |
Depreciation & Amortization | 20.55 | 19.35 | 20.52 | 21.57 | 23.62 |
Other Amortization | - | - | - | 0.52 | 1.28 |
Loss (Gain) From Sale of Assets | -1.47 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | 0.01 | 0.72 | 0.13 | 0.84 |
Other Operating Activities | 15.82 | 15.42 | 15.28 | 14.55 | 18.57 |
Change in Accounts Receivable | -4.11 | 3.07 | 0.68 | 1.78 | -8.38 |
Change in Inventory | -1.44 | -2.72 | 1.52 | 0.07 | -1.78 |
Change in Accounts Payable | 4.82 | 2.09 | -2.56 | -11.97 | 7.78 |
Operating Cash Flow | 54.61 | 52.64 | 45.96 | 45.91 | 65.84 |
Operating Cash Flow Growth | 3.75% | 14.54% | 0.10% | -30.27% | -7.19% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -9.61 | -5.84 | -7.4 | -5.71 | -4.09 |
Cash Acquisitions | -4.5 | -1.37 | -10.18 | -15.73 | -17.95 |
Divestitures | 3.08 | - | - | - | - |
Investment in Securities | -0.27 | -0.13 | -0.32 | -2.88 | -2.85 |
Other Investing Activities | - | - | -0.28 | 29.75 | - |
Investing Cash Flow | -11.3 | -7.33 | -18.18 | 5.43 | -24.88 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 2.41 | 1.56 | 41.22 | 2.38 | 5.31 |
Long-Term Debt Repaid | -20.78 | -24.64 | -42.45 | -17.61 | -22.08 |
Net Debt Issued (Repaid) | -18.37 | -23.09 | -1.23 | -15.23 | -16.76 |
Common Dividends Paid | -8.29 | -6.48 | -48.9 | -10.07 | -4.31 |
Other Financing Activities | -14.45 | -13.07 | -13.25 | -14.8 | -8.22 |
Financing Cash Flow | -41.11 | -42.64 | -63.38 | -40.1 | -29.29 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0.13 | 0.79 | 1.83 | -3.81 |
Net Cash Flow | 2.2 | 2.8 | -34.81 | 13.06 | 7.85 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 45.01 | 46.8 | 38.56 | 40.2 | 61.74 |
Free Cash Flow Growth | -3.84% | 21.38% | -4.07% | -34.90% | -6.40% |
Free Cash Flow Margin | 8.24% | 8.94% | 7.65% | 8.14% | 12.91% |
Free Cash Flow Per Share | 0.31 | 0.33 | 0.27 | 0.28 | 0.43 |
Levered Free Cash Flow | 32.42 | 32.29 | 20.89 | 8.42 | 53.39 |
Unlevered Free Cash Flow | 38.57 | 38.84 | 27.31 | 13.3 | 57.26 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 9.87 | 10.51 | 10.19 | 7.8 | 6.18 |
Cash Income Tax Paid | 9.92 | 8.63 | 8.02 | - | 10.09 |
Change in Working Capital | -0.68 | 1.88 | -2.59 | -14.29 | -2.37 |